Obama Tax Plan Delivers Softer Blow Than Expected
This article was originally published in The Tan Sheet
Executive SummaryThe Obama administration's proposal to close a tax loophole for U.S. multinational firms would not have as large an impact as some pharmaceutical companies feared
You may also be interested in...
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.